FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Anna-Maria Ammon
List of publications:
BibTeX-Download
Department of Medicine 5 – Haematology and Oncology
Publications
(8)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Targeted inhibition of protein synthesis renders cancer cells vulnerable to apoptosis by unfolded protein response (2023)
Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, et al.
Journal article
Block of Counter-Regulation By Inhibition of Protein Synthesis Sensitizes Cancer Cells to IRE1a-Mediated Apoptosis Following Unfolded Protein Response (2022)
Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, et al.
Conference contribution
Targeted Inhibition of Protein Biosynthesis sensitizes Cancer Cells to IRE1a-mediated Apoptosis as a Consequence of the unfolded protein response (2022)
Gsottberger F, Meier C, Ammon AM, Parker S, Wendland K, George R, Petkovic S, et al.
Conference contribution
Reduced cytotoxicity by mutation of lysine 590 of Pseudomonas exotoxin can be restored in an optimized, lysine-free immunotoxin. (2022)
Ammon AM, Mellenthin L, Emmerich C, Naschberger E, Stürzl M, Mackensen A, Müller F
Journal article
Synergy of simultaneous activation of cell death pathways of unfolded protein response and of protein synthesis inhibition converges at IRE1a-immunotoxins generate a therapeutic window (2021)
Gsottberger F, Meier C, Ammon AM, Petkovic S, Mellenthin L, Krumbholz M, Metzler M, et al.
Conference contribution
Improved Pseudomonas exotoxin and Mertansine-based Duotoxins for the treatment of hematologic malignancies (2021)
Ammon AM, George R, Mellenthin L, Mackensen A, Mueller F
Conference contribution
Triton X-114 and Amine-Based Wash Strategy Reduces Lipopolysaccharides to FDA Limit and Achieves Purer, More Potent Recombinant Immunotoxin (2021)
George R, Gsottberger F, Ammon AM, Wendland K, Mellenthin L, Mackensen A, Müller F
Journal article
Development of pseudomonas exotoxin based Duotoxins for the treatment of hematologic malignancies (2019)
Ammon AM, Emmerich C, Mellenthin L, Mackensen A, Müller F
Conference contribution